Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Inflammation × Pioglitazone × Clear all

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Conditions

Urinary Bladder Neoplasms 2 Diabetes Mellitus, Type 2 2 Diabetes Mellitus 2 Pancreatic Neoplasms 1 Metabolic Syndrome 1 Inflammation 1 Hypogonadism 1

Interventions

Blood Specimen Collection 2 ziprasidone 1 semaglutide 1 bupropion hydrochloride, naltrexone hydrochoride drug combination 1 Zolpidem 1 Weights and Measures 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Tranexamic Acid 1 Topiramate 1 Tobramycin 1 Tirzepatide 1 Surgical Procedures, Operative 1 Spironolactone 1 Sevelamer 1 Rocuronium 1 Qsymia 1 Piperacillin, Tazobactam Drug Combination 1 Pioglitazone 1 Phentermine 1 Pentobarbital 1 Oxycodone 1 Nifedipine 1 Neoadjuvant Therapy 1 Naltrexone 1 Nafcillin 1 Molindone 1 Methylprednisolone 1 Mastectomy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00743327 2012-08-06

ADT

National Institutes of Health Clinical Center (CC)

Diabetes Mellitus, Hypogonadism, Inflammation, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡